Skip to main content
Erschienen in:

04.09.2024 | Original Article

Does Gastroesophageal Reflux Disease Increase the Risk of Sepsis and Its 28-day Mortality? A Causal Study Using a Mendelian Randomization Approach

verfasst von: Runquan Zhou, Wenjuan Li, Fan Wu, Yuanhui Sheng, Shan Xu, Yi Liu, Dan Zhang, Mingxing Wang

Erschienen in: Digestive Diseases and Sciences | Ausgabe 10/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

Gastroesophageal reflux disease (GERD) is a prevalent gastrointestinal disorder. Recent studies indicate that GERD may exert systemic effects, potentially elevating the risk of severe infections, including sepsis. Nevertheless, the causal relationship between GERD and sepsis, as well as sepsis-related 28-day mortality, remains uncertain.

Aim

The aim of this study is to investigate the causal relationship between GERD and the risk of sepsis, including 28-day mortality of sepsis.

Methods

This study utilized a two-sample Mendelian Randomization (MR) approach to analyze data from publicly available genome-wide association studies (GWAS) databases (https://​gwas.​mrcieu.​ac.​uk/​). The analysis comprised 129,080 cases and 473,524 controls for GERD; 11,643 patients and 474,841 controls for sepsis; and 1,896 patients and 484,588 controls for 28-day mortality from sepsis. The objective was to evaluate the causal impact of GERD on the risk of sepsis and 28-day sepsis mortality. Genetic variation data pertinent to GERD were obtained from the most recent genome-wide association studies (GWAS). The primary analysis employed the Inverse Variance Weighted (IVW) method. Sensitivity and pleiotropy analyses were performed to validate the robustness of the findings.

Results

MR analysis revealed a notable link between genetically predicted GERD and increased sepsis risk (odds ratio [OR] 1.37, 95% confidence interval [CI] 1.24–1.52; p = 2.79 × 10–9). Moreover, GERD correlated with elevated 28-day mortality of sepsis (OR 1.44, 95% CI 1.11–1.85; p = 5.34 × 10–3). These results remained consistent throughout various sensitivity analyses, indicating their resilience against potential pleiotropy and other biases.

Conclusion

This study indicates that genetic predisposition to GERD may be linked to an elevated risk of sepsis and its associated 28-day mortality. However, the study does not establish a direct causal relationship for GERD itself, nor does it assess the impact of GERD treatment. Further research is needed to explore the underlying mechanisms and potential therapeutic interventions involved.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Li J, Shen L, Qian K. Global, regional, and national incidence and mortality of neonatal sepsis and other neonatal infections, 1990–2019. Front Public Health. 2023;11:1139832.CrossRefPubMedPubMedCentral Li J, Shen L, Qian K. Global, regional, and national incidence and mortality of neonatal sepsis and other neonatal infections, 1990–2019. Front Public Health. 2023;11:1139832.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the global burden of disease study. Lancet. 2020;395:200–211.CrossRefPubMedPubMedCentral Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the global burden of disease study. Lancet. 2020;395:200–211.CrossRefPubMedPubMedCentral
3.
4.
Zurück zum Zitat Zou M, Zhang W, Xu Y, Zhu Y. Relationship between COPD and GERD: a bibliometrics analysis. Int J Chron Obstr Pulm Dis. 2022;17:3045–3059.CrossRef Zou M, Zhang W, Xu Y, Zhu Y. Relationship between COPD and GERD: a bibliometrics analysis. Int J Chron Obstr Pulm Dis. 2022;17:3045–3059.CrossRef
5.
Zurück zum Zitat Sakae TM, Pizzichini MM, Teixeira PJ, Silva RM, Trevisol DJ, Pizzichini E. Exacerbations of COPD and symptoms of gastroesophageal reflux: a systematic review and meta-analysis. J Bras Pneumol. 2013;39:259–271.CrossRefPubMedPubMedCentral Sakae TM, Pizzichini MM, Teixeira PJ, Silva RM, Trevisol DJ, Pizzichini E. Exacerbations of COPD and symptoms of gastroesophageal reflux: a systematic review and meta-analysis. J Bras Pneumol. 2013;39:259–271.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Morehead RS. Gastro-oesophageal reflux disease and non-asthma lung disease. Eur Respir Rev. 2009;18:233–243.CrossRefPubMed Morehead RS. Gastro-oesophageal reflux disease and non-asthma lung disease. Eur Respir Rev. 2009;18:233–243.CrossRefPubMed
7.
9.
Zurück zum Zitat Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement. JAMA. 2021;326:1614–1621.CrossRefPubMed Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement. JAMA. 2021;326:1614–1621.CrossRefPubMed
10.
Zurück zum Zitat Relton CL, Davey SG. Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease. Int J Epidemiol. 2012;41:161–176.CrossRefPubMedPubMedCentral Relton CL, Davey SG. Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease. Int J Epidemiol. 2012;41:161–176.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Sekula P, Del Greco MF, Pattaro C, Kottgen A. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol. 2016;27:3253–3265.CrossRefPubMedPubMedCentral Sekula P, Del Greco MF, Pattaro C, Kottgen A. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol. 2016;27:3253–3265.CrossRefPubMedPubMedCentral
12.
13.
Zurück zum Zitat Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512–525.CrossRefPubMedPubMedCentral Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512–525.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Lei P, Xu W, Wang C, Lin G, Yu S, Guo Y. Mendelian randomization analysis reveals causal associations of polyunsaturated fatty acids with sepsis and mortality risk. Infect Dis Ther. 2023;12:1797–1808.CrossRefPubMedPubMedCentral Lei P, Xu W, Wang C, Lin G, Yu S, Guo Y. Mendelian randomization analysis reveals causal associations of polyunsaturated fatty acids with sepsis and mortality risk. Infect Dis Ther. 2023;12:1797–1808.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693–698.CrossRefPubMedPubMedCentral Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693–698.CrossRefPubMedPubMedCentral
16.
17.
Zurück zum Zitat Pneumatikos J, Koulouras B, Frangides C, Goe D, Nakos G. Cisapride decreases gastric content aspiration in mechanically ventilated patients. Crit Care. 1999;3:39–43.CrossRefPubMedPubMedCentral Pneumatikos J, Koulouras B, Frangides C, Goe D, Nakos G. Cisapride decreases gastric content aspiration in mechanically ventilated patients. Crit Care. 1999;3:39–43.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Diamant NEJGMo. Pathophysiology of gastroesophageal reflux disease. 2006. Diamant NEJGMo. Pathophysiology of gastroesophageal reflux disease. 2006.
19.
Zurück zum Zitat Ivashkin V, Evsyutina Y, Trukhmanov A, Lyamina S, Malyshev I. Systemic inflammatory response in patients with gastroesophageal reflux disease. Am J Clin Med Res. 2015;3:64–9. Ivashkin V, Evsyutina Y, Trukhmanov A, Lyamina S, Malyshev I. Systemic inflammatory response in patients with gastroesophageal reflux disease. Am J Clin Med Res. 2015;3:64–9.
20.
Zurück zum Zitat Clayton S, Cauble E, Kumar A, Patil N, Ledford D, Kolliputi N et al. Plasma levels of TNF-alpha, IL-6, IFN-gamma, IL-12, IL-17, IL-22, and IL-23 in achalasia, eosinophilic esophagitis (EoE), and gastroesophageal reflux disease (GERD). BMC Gastroenterol. 2019;19:28.CrossRefPubMedPubMedCentral Clayton S, Cauble E, Kumar A, Patil N, Ledford D, Kolliputi N et al. Plasma levels of TNF-alpha, IL-6, IFN-gamma, IL-12, IL-17, IL-22, and IL-23 in achalasia, eosinophilic esophagitis (EoE), and gastroesophageal reflux disease (GERD). BMC Gastroenterol. 2019;19:28.CrossRefPubMedPubMedCentral
21.
22.
Zurück zum Zitat Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB. Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal. 2014;20:1126–1167.CrossRefPubMedPubMedCentral Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB. Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal. 2014;20:1126–1167.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Froio S, Valenza F. Aspiration of gastric contents in the critically ill Oxford Textbook of Critical Care. Oxford: Oxford University Press; 2016.CrossRef Froio S, Valenza F. Aspiration of gastric contents in the critically ill Oxford Textbook of Critical Care. Oxford: Oxford University Press; 2016.CrossRef
24.
Zurück zum Zitat Iov DE, Barboi OB, Floria M, Neamtu A, Iliescu R, Drug VL. pepsin and the lung-exploring the relationship between micro-aspiration and respiratory manifestations of gastroesophageal reflux disease. J Pers Med. 2022;12(8). Iov DE, Barboi OB, Floria M, Neamtu A, Iliescu R, Drug VL. pepsin and the lung-exploring the relationship between micro-aspiration and respiratory manifestations of gastroesophageal reflux disease. J Pers Med. 2022;12(8).
25.
Zurück zum Zitat Dong R, Zhang Q, Peng H. Gastroesophageal reflux disease and the risk of respiratory diseases: a Mendelian randomization study. J Transl Med. 2024;22:60.CrossRefPubMedPubMedCentral Dong R, Zhang Q, Peng H. Gastroesophageal reflux disease and the risk of respiratory diseases: a Mendelian randomization study. J Transl Med. 2024;22:60.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Iov DE, Bărboi OB, Floria M, Neamțu A, Iliescu R, Drug VL. Pepsin and the lung-exploring the relationship between micro-aspiration and respiratory manifestations of gastroesophageal reflux disease. J Pers Med. 2022;12(8). Iov DE, Bărboi OB, Floria M, Neamțu A, Iliescu R, Drug VL. Pepsin and the lung-exploring the relationship between micro-aspiration and respiratory manifestations of gastroesophageal reflux disease. J Pers Med. 2022;12(8).
27.
Zurück zum Zitat Zhang X, Liu H, Hashimoto K, Yuan S, Zhang J. The gut-liver axis in sepsis: interaction mechanisms and therapeutic potential. Crit Care. 2022;26:213.CrossRefPubMedPubMedCentral Zhang X, Liu H, Hashimoto K, Yuan S, Zhang J. The gut-liver axis in sepsis: interaction mechanisms and therapeutic potential. Crit Care. 2022;26:213.CrossRefPubMedPubMedCentral
28.
29.
Zurück zum Zitat Bercis Imge U, Gulberk U. Intestinal Barrier Dysfunction, Bacterial translocation and inflammation: Deathly Triad in Sepsis. Rijeka: IntechOpen; 2021. p. Ch. 15. Bercis Imge U, Gulberk U. Intestinal Barrier Dysfunction, Bacterial translocation and inflammation: Deathly Triad in Sepsis. Rijeka: IntechOpen; 2021. p. Ch. 15.
30.
Metadaten
Titel
Does Gastroesophageal Reflux Disease Increase the Risk of Sepsis and Its 28-day Mortality? A Causal Study Using a Mendelian Randomization Approach
verfasst von
Runquan Zhou
Wenjuan Li
Fan Wu
Yuanhui Sheng
Shan Xu
Yi Liu
Dan Zhang
Mingxing Wang
Publikationsdatum
04.09.2024
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 10/2024
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-024-08625-0

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Vorhofflimmern: Antikoagulation vor Schlaganfall von Vorteil

Erleiden Menschen mit Vorhofflimmern einen ischämischen Schlaganfall, ist dieser weniger schwer, auch sind Infarktgröße und Blutungsrisiko geringer, wenn sie zuvor orale Antikoagulanzien erhalten haben. Die Art der Antikoagulation spielt dabei keine Rolle.

Frühe CLL-Therapie: BTK-Hemmer verlängert EFS und PFS, aber nicht OS

Auch nach sechs Jahren ergibt sich kein Überlebensvorteil einer Therapie mit dem BTK-Hemmer Ibrutinib für Menschen mit frühem CLL-Stadium und erhöhtem Progressionsrisiko. Die Progressionsrate wird mit der Behandlung jedoch um über 80% gesenkt.

Mehr Cholesterin im Essen = höheres Herzinfarktrisiko

Je mehr Cholesterin man täglich über die Nahrung zu sich nimmt, desto höher ist offenbar das Herzinfarktrisiko – das legt eine Studie mit US-Veteranen zumindest für Männer nahe.

Antikoagulation bei Vorhofflimmern: Sind DOAK noch zu toppen?

Gegen Thromboembolien so wirksam wie ein DOAK, bei zugleich geringerem Blutungsrisiko – werden Faktor-XI-Hemmer als neue Antikoagulanzien dieser Erwartung gerecht? Eine aktuell publizierte Vergleichsstudie gibt darüber Aufschluss.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.